XRF — XRF Scientific Cashflow Statement
0.000.00%
- AU$297.94m
- AU$288.58m
- AU$59.45m
- 90
- 36
- 89
- 82
Annual cashflow statement for XRF Scientific, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.861 | 0.002 | 0.086 | 0.281 | 0.263 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 4.51 | 3.15 | 8.42 | 8.09 | 10.1 |
| Capital Expenditures | -0.653 | -0.519 | -0.782 | -1.64 | -2.15 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -0.592 | 0 | — | -0.06 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.653 | -1.11 | -0.782 | -1.64 | -2.21 |
| Financing Cash Flow Items | — | — | — | — | -2.36 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -2.24 | -0.649 | -3.88 | -4.8 | -7.75 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.62 | 1.39 | 3.75 | 1.65 | 0.183 |